News

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...
The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...
A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.